07 November 2024
Chairman of Egypt Health Care Authority Meets with AstraZeneca Egypt's President and Delegation from the Chinese Healthcare Technology Consortium Specializing in AI

Chairman of Egypt Health Care Authority Meets with AstraZeneca Egypt's President and Delegation from the Chinese Healthcare Technology Consortium Specializing in AI

Chairman of Egypt Health Care Authority: Discussed cooperation with the Chinese companies' delegation specializing in several areas, most notably digital diagnostics, genetic testing for tumors, early disease detection, corneal exams for diabetes patients, supporting the digitization of radiology and laboratory systems, and activating the use of artificial intelligence.

Chairman of Egypt Health Care Authority: Discussed cooperation with the Chinese companies' delegation to support the setup and operation of the virtual hospital in Ismailia in collaboration with AstraZeneca Egypt, as well as to support the establishment of an Innovation Hub using AI to enhance the quality of healthcare.

Chairman of Egypt Health Care Authority: The Egyptian market is promising and opens up multiple opportunities for investment in healthcare. We aim to strengthen Egyptian-Chinese relations under the BRICS framework to achieve a sustainable healthcare and investment partnership... with three main pillars for successful investments: 'Quality,' 'Accreditation,' and 'Safety.'

President of AstraZeneca Egypt: Commends the success of the strategic partnership with Egypt Health Care Authority and emphasizes the importance of enhancing public-private partnerships to achieve sustainable development.

Chairman of the Chinese Healthcare Technology Consortium: We see great opportunities for collaboration with Egypt Health Care Authority, given its technological expertise and achievements in digitizing the healthcare sector, which can be developed and built upon.


Dr. Ahmed El-Sobky, Chairman of Egypt Health Care Authority and General Supervisor of the Universal Health Insurance Project, met with Dr. Hatem El-Wardani, President of AstraZeneca Egypt, and a delegation from the Chinese consortium of companies specializing in AI-supported healthcare solutions, at the headquarters of the Egypt Health Care Authority in the New Administrative Capital.

During the meeting, avenues of cooperation were discussed with the delegation of Chinese companies specializing in AI-supported healthcare solutions in several fields, most notably digital diagnostics for tumors, genetic testing for tumors, early disease detection, corneal examinations for diabetes patients, supporting the digitization of radiology and laboratory systems, and activating the use of artificial intelligence.

The Chairman of Egypt Health Care Authority indicated that the meeting also addressed cooperation with the Chinese companies' delegation to support the setup and operation of the authority's virtual hospital in Ismailia, in collaboration with AstraZeneca Egypt, as well as supporting the establishment of an Innovation Hub using AI to improve healthcare quality.

Dr. Ahmed El-Sobky stated: "We aim to strengthen Egyptian-Chinese relations within the BRICS framework to achieve a sustainable healthcare and investment partnership." He emphasized that the Egyptian market is promising for investment opportunities in healthcare, highlighting the three main pillars for successful investments: 'Quality,' 'Accreditation,' and 'Safety,' which will bring a qualitative leap in the quality of health services provided to citizens. He also stressed the importance of developing and employing digital health technologies to support the quality and efficiency of healthcare.

Dr. Hatem El-Wardani, President of AstraZeneca Egypt, commended the strategic partnership with Egypt Health Care Authority, emphasizing the importance of enhancing public-private partnerships to achieve a qualitative leap in healthcare services in Egypt. He added, "This cooperation represents a model of integration between governmental and private entities, as we seek together to improve patients' lives and provide innovative medical solutions that contribute to supporting the quality of healthcare."

Mr. Xin Chandler, Chairman of the Chinese Healthcare Technology Consortium, stated, "We see great opportunities for collaboration with Egypt Health Care Authority, given its technological expertise and achievements in digitizing the healthcare sector, which can be developed and built upon."

The meeting was attended by several representatives from the Egypt Health Care Authority, including Dr. Magdy Bakr, Technical Affairs Advisor to the Chairman, Dr. Ahmed Hammad, Policy and Health Systems Advisor to the Chairman and General Director of the Technical Office, Major General Hisham Shendi, Telemedicine and Health Technology Advisor to the Chairman and General Director of the General Administration of Information Systems and Digital Transformation, Dr. Sherif Kamal, Pharmacy and Drug Management Advisor to the Chairman, Dr. Mohamed Shaban, Director of the Evaluation and Monitoring Department, Dr. Heba Abdel Aziz, Technical Supervisor for Telemedicine Units, Dr. Radwa Abdel Azim, Oncology File Manager at the Chairman's Technical Office, and Dr. Nashwa Gouda, Member of the Chairman's Technical Office.